VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.553
-0.024 (-4.13%)
At close: Feb 21, 2025, 4:00 PM
0.570
+0.017 (3.17%)
After-hours: Feb 21, 2025, 6:08 PM EST
VolitionRx Employees
VolitionRx had 110 employees as of December 31, 2023. The number of employees increased by 6 or 5.77% compared to the previous year.
Employees
110
Change (1Y)
6
Growth (1Y)
5.77%
Revenue / Employee
$11,689
Profits / Employee
-$271,570
Market Cap
51.20M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
VNRX News
- 16 days ago - Volition Signs First Commercial Project Utilizing Rapid High-Throughput Model in the Study of NETosis - PRNewsWire
- 17 days ago - Volition to Host Virtual Investor Event on Nu.Q® NETs, "Casting a New Light on Sepsis Management", on February 14, 2025 - PRNewsWire
- 23 days ago - Large clinical study establishes Nu.Q® NETs H3.1 as an independent predictor of 28-day mortality in sepsis - PRNewsWire
- 6 weeks ago - Volition Issues Business Review 2024 - PRNewsWire
- 2 months ago - VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants - PRNewsWire
- 2 months ago - Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening - PRNewsWire
- 2 months ago - VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering - PRNewsWire
- 3 months ago - VolitionRx Limited (VNRX) Q3 2024 Earnings Call Transcript - Seeking Alpha